The recurring revenue story behind Serina Therapeutics SER Q4 2025 EPS Exceeds Expectations Why Lyft LYFT could be the anchor your portfolio needs 049 20260508 What CHS B Pref 3 CHSCM does that its rivals cannot replicate CHSCM Recent Quarter Earnings CHS B Pref 3 does not disclose EPS or revenue data HST Host posts 66 percent EPS beat for Q4 2025 with shares rising modestly after earnings release Kazatomprom Reports 17 Production Surge in Third Quarter Uranium Output on the Rise